The Effect of Aggressive Versus Standard Lipid Lowering by Atorvastatin on Diabetic Dyslipidemia: The DALI Study: A Double-Blind, Randomized, Placebo-Controlled Trial in Patients With Type 2 Diabetes and Diabetic Dyslipidemia

Diabetes Care - United States
doi 10.2337/diacare.24.8.1335
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Diabetes Association


Related search